News

Proud to partner with North Carolina BioSciences Organization

The North Carolina BioSciences Organization (NCBIO) recently welcomed ARANZ Medical as one of their newest members. NCBIO provides their partner organizations with industry information…

Two new US patents further endorse ARANZ Medical’s leadership in skin surface assessment technology

The addition of two more US patents to ARANZ Medical’s portfolio of skin surface measurement products further strengthen and secure the company’s IP and…

ARANZ Medical’s pedigree in clinical trials makes Silhouette® the obvious choice for new research

ARANZ Medical’s Silhouette skin imaging and measuring solutions have powered more than 100 clinical trials since 2007, and are proving to be a reliable…

ARANZ Medical Launches Two New Silhouette® Image Capture Products

Two new smart-phone based imaging products, SilhouetteLite+ and SilhouetteLite, recently launched by ARANZ Medical Limited have been adopted by Promore Pharma AB (Solna, Sweden)…

ARANZ Medical announces issuance of new patent and 2017 closing of NZ$3million

ARANZ Medical announced today the issuance of United States Patent 9,861,285, Handheld Skin Measuring or Monitoring Device, the most recent patent to be issued…

Lakewood-Amedex Inc. Completes Clinical Trial Recruitment for Final Cohort of the Company’s Phase 1/2a Program in Patients with Infected Diabetic Foot Ulcers

Lakewood-Amedex Inc., a leading developer of novel anti-infective pharmaceuticals, announced today the completion of patient treatment in the final cohort of the Company’s Phase…